Merck Operating Expenses 2010-2024 | MRK

Merck operating expenses for the twelve months ending December 31, 2024 were $43.949B, a 23.11% decline year-over-year.

  • Merck annual operating expenses for 2024 were $43.947B, a 23.12% decline from 2023.
  • Merck annual operating expenses for 2023 were $57.161B, a 39.41% increase from 2022.
  • Merck annual operating expenses for 2022 were $41.001B, a 15.48% increase from 2021.

Merck Operating Expenses 2010-2024 | MRK

  • Merck annual operating expenses for 2024 were $43.947B, a 23.12% decline from 2023.
  • Merck annual operating expenses for 2023 were $57.161B, a 39.41% increase from 2022.
  • Merck annual operating expenses for 2022 were $41.001B, a 15.48% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B